a surface-penetrating sealant; contains Bis-GMA, UDMA, TEGDMA, THFMA, photoinitiators, accelerator, UV absorber & stabilizer
Networked: 46 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Tezel, Gülgün: 3 articles (04/2009 - 02/2004)
2. Wax, Martin B: 3 articles (04/2009 - 02/2004)
3. Cruje, C: 1 article (03/2015)
4. Chithrani, B D: 1 article (03/2015)
5. Niu, X Q: 1 article (01/2015)
6. Syga, Marie Isabel: 1 article (01/2015)
7. Fu, X: 1 article (01/2015)
8. Pu, J: 1 article (01/2015)
9. Fan, Y D: 1 article (01/2015)
10. Zhao, X X: 1 article (01/2015)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
03/01/2015 - "A properly designed NP system with both PEG and cell membrane targeting peptides can be used to protect it from the immune system and promote internalization by cells upon entry into tumor environment."
01/01/2005 - "Instead, it is becoming clear that MMPs and their natural inhibitors have multiple biological functions that not only challenge our view on how MMPs promote metastasis, but also raise for the first time the idea that secretion of MMPs by the host could protect it from tumor growth, at least in some types of cancer or at specific stages of tumor progression."
08/01/2010 - "UCH-L1 possesses deubiquitinating activity and dimerization-dependent ubiquitin ligase activity, and functions as a mono-ubiquitin stabilizer; UCH-L3 does both deubiquitinating and deneddylating activity, except dimerization or ligase activity, and unlike UCH-L1, can interact with Lys48-linked Ub dimers to protect it from degradation and in the meanwhile to inhibit its hydrolase activity; UCH37 is responsible for the deubiquitinating activity in the 19S proteasome regulatory complex, and as indicated by the recent study, UCH37 is also associated with the human Ino80 chromatin-remodeling complex (hINO80) in the nucleus and can be activated via transient association of 19S regulatory particle- or proteasome-bound hRpn13 with hINO80; BAP1, binding to the wild-type BRCA1 RING finger domain, is regarded as a tumor suppressor, but for such suppressing activity, as demonstrated otherwise, both deubiquitinating activity and nucleus localization are required. "
02/27/2014 - "The addition of a phosphoramidate motif to the gemcitabine can protect it against many of the key cancer resistance mechanisms. "
3. Rupture
4. Wounds and Injuries (Trauma)
5. Ischemia

Related Drugs and Biologics

1. Small Interfering RNA (siRNA)
2. Endonucleases
3. Proteasome Endopeptidase Complex (Proteasome)
4. Ubiquitin
5. gemcitabine
6. Bone Morphogenetic Protein 7
7. Nucleotide Aptamers
8. 14-3-3 Proteins (14-3-3 Protein)
9. Intercellular Signaling Peptides and Proteins (Growth Factors)
10. Matrix Metalloproteinases

Related Therapies and Procedures

1. Transplants (Transplant)